Jefferies Group Analysts Give Sanofi SA (SAN) a €74.00 Price Target
Sanofi SA (EPA:SAN) received a €74.00 ($82.22) target price from Jefferies Group in a research note issued to investors on Thursday. The firm currently has a a “neutral” rating on the stock.
Several other equities analysts also recently commented on the company. JPMorgan Chase & Co. set a €71.00 ($78.89) price objective on Sanofi SA and gave the company a “sell” rating in a research report on Thursday, September 15th. Societe Generale set a €100.00 ($111.11) price target on Sanofi SA and gave the stock a “buy” rating in a research report on Monday, August 1st. Kepler Capital Markets set a €89.00 ($98.89) price target on Sanofi SA and gave the stock a “buy” rating in a research report on Thursday, August 11th. BNP Paribas set a €78.00 ($86.67) price target on Sanofi SA and gave the stock a “neutral” rating in a research report on Wednesday, September 14th. Finally, Berenberg Bank set a €93.00 ($103.33) price target on Sanofi SA and gave the stock a “buy” rating in a research report on Thursday, September 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have given a buy rating to the company. Sanofi SA has a consensus rating of “Hold” and a consensus price target of €86.65 ($96.27).
Shares of Sanofi SA (EPA:SAN) opened at 67.59 on Thursday. The company has a market capitalization of €86.99 billion and a P/E ratio of 21.02. Sanofi SA has a 12-month low of €22.81 and a 12-month high of €68.17. The company has a 50-day moving average price of €25.98 and a 200 day moving average price of €25.76.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/jefferies-group-analysts-give-sanofi-sa-san-a-74-00-price-target.html
Sanofi SA Company Profile
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.